Autophagy and mTOR inhibition as mechanisms for combatting chemoresistance to standard chemotherapy: Final results of a phase I study of infusional cyclophosphamide (cy), pulse dexamethasone (dex), rapamycin (rapa) and hydroxychloroquine (HCQ)

Emma C. Scott,Shara Reasor-Heard, K. Floyd,Byung Park,Phoebe Trubowitz,Eva Medvedova,Stephen E. Spurgeon,Stephen D. Smith, Anne Kratz,Miranda Gordon, Matthew B. Siegel,Selina Qiuying Liu, R. Arora,Marc Loriaux,Edward A. Stadtmauer,Ravi K. Amaravadi,Dan T. Vogl,Richard T. Maziarz

Clinical Lymphoma, Myeloma & Leukemia（2015）

引用 0|浏览9

暂无评分

摘要

PO-350 Autophagy and mTOR inhibition as mechanisms for combatting chemoresistance to standard chemotherapy: Final results of a phase I study of infusional cyclophosphamide (cy), pulse dexamethasone (dex), rapamycin (rapa) and hydroxychloroquine (HCQ) E.C. Scott, S. Reasor-Heard, K. Floyd, B. Park, P. Trubowitz, E. Medvedova, S.E. Spurgeon, S.D. Smith, A. Kratz, M. Gordon, M. Siegel, S.Q. Liu, R. Arora, M. Loriaux, E. Stadtmauer, R. Amaravadi, D.T. Vogl, R.T. Maziarz The Knight Cancer Institute, Oregon Health and Science University; The Abramson Cancer Center, the University of Pennsylvania

查看译文

关键词

autophagy,mtor inhibition,infusional cyclophosphamide,standard chemotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要